Home › NDC Lookup › RxCUI directory › RxCUI 2283523

{14 (cenobamate 12.5 MG Oral Tablet) / 14 (cenobamate 25 MG Oral Tablet) } Pack — RxCUI 2283523

RxNorm drug concept · Generic pack
RxCUI 2283523 Generic pack · GPCK ● Current RxNorm concept 11 FDA products 12 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2283523
Official name{14 (cenobamate 12.5 MG Oral Tablet) / 14 (cenobamate 25 MG Oral Tablet) } Pack
Concept typeGeneric pack (GPCK)
RxNorm statusCurrent RxNorm concept
Also known ascenobamate 12.5 MG Oral Tablet (14) / cenobamate 25 MG Oral Tablet (14) Titration Pack
FDA products mapped11
Package NDCs mapped12
Reported Medicaid activity (SDUD)139,992 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Cenobamate: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Cenobamate, sold as Xcopri, treats partial-onset seizures in adults. These are seizures that begin in one part of the brain. Your prescriber will tailor how you use it.
  • Raising the dose slowly lowers the chance of a serious allergic reaction called DRESS. Cases, including one death, happened with fast increases. Please stick to the schedule your p...
  • Sleepiness, dizziness, tiredness, double vision, and headache are the most common. Be careful with driving until you know how it affects you. Call your doctor if these are hard to...
  • Call for fever with a rash, swollen glands, or facial swelling. Also call for yellow skin or eyes, dark urine, upper right belly pain, or unexplained nausea and vomiting. Tell them...
📖 Read our full Cenobamate guide →

🕸️ Concept Web — How {14 (cenobamate 12.5 MG Oral Tablet) / 14 (cenob... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept {14 (cenobamate 12.5 MG Oral Tablet) / 14 (cenobamate 25 MG Oral Tablet) } Pack RxCUI 2283523

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Cenobamate 2265690
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Xcopri 2265696
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Cenobamate Oral Tablet 2265694
    • Cenobamate Oral Product 2265692
    • Cenobamate Pill 2265693
    • Cenobamate Oral Tablet [Xcopri] 2265698
    • Xcopri Oral Product 2265699
    • Xcopri Pill 2265700
    • Pack 746839
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 8

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

  5. Packs 1

    Fixed collections of drugs packaged and sold together, like dose packs.

Showing up to 8 concepts per family — 19 of 20 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Brand-Name Concepts

📦 FDA Products & Package NDCs

11 products · 12 package NDCs
12 package NDCs map to RxCUI 2283523 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
71699-0025-30 30 TABLET, FILM COATED in 1 BOTTLE (71699-025-30) Xcopri SK Life Science, Inc. 2024-04-06
71699-0050-30 30 TABLET, FILM COATED in 1 BOTTLE (71699-050-30) Xcopri SK Life Science, Inc. 2021-04-30
71699-0050-99 30 TABLET, FILM COATED in 1 BOTTLE (71699-050-99) Xcopri SK Life Science, Inc. 2021-04-30
71699-0100-30 30 TABLET, FILM COATED in 1 BOTTLE (71699-100-30) Xcopri SK Life Science, Inc. 2020-03-12
71699-0103-56 1 KIT in 1 CARTON (71699-103-56) * 1 TABLET, FILM COATED i... Xcopri Maintenance Pack SK Life Science, Inc. 2020-03-12
71699-0104-56 1 KIT in 1 CARTON (71699-104-56) * 1 TABLET, FILM COATED i... Xcopri Maintenance Pack SK Life Science, Inc. 2021-04-30
71699-0150-30 30 TABLET, FILM COATED in 1 BOTTLE (71699-150-30) Xcopri SK Life Science, Inc. 2020-03-12
71699-0200-30 30 TABLET, FILM COATED in 1 BOTTLE (71699-200-30) Xcopri SK Life Science, Inc. 2020-03-12
71699-0201-28 1 KIT in 1 CARTON (71699-201-28) * 1 TABLET in 1 BLISTER P... Xcopri Titration Pack SK Life Science, Inc. 2020-03-12
71699-0202-28 1 KIT in 1 CARTON (71699-202-28) * 1 TABLET, FILM COATED i... Xcopri Titration Pack SK Life Science, Inc. 2020-03-12
71699-0203-28 1 KIT in 1 CARTON (71699-203-28) * 1 TABLET, FILM COATED i... Xcopri Titration Pack SK Life Science, Inc. 2020-03-12
71699-0204-14 14 BLISTER PACK in 1 CARTON (71699-204-14) / 1 TABLET in 1... Xcopri SK Life Science, Inc. 2026-02-01
Observed labelers: SK Life Science, Inc. (12) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.